PECAM1 and neoplasm: Expression analyses of biomarkers such as CD31, N-cadherin, IL-6, IFN-γ, CD8, p16, p21, and p53 further demonstrated that GDNPs@ICG effectively reduced angiogenesis, suppressed metastasis, activated anti-tumor immune responses, and promoted tumor cell senescence (30).